Development & Reproduction
Korean Society of Developmental Biology
Original research paper

Effects of 17β-estradiol, Interleukin-1β, and Human Chorionic Gonadotropin on Activity and mRNA Expression of Plasminogen Activators in Porcine Endometrial Cells

Yong Hwangbo1, Hee-Tae Cheong2, Boo-Keun Yang1, Choon-Keun Park1,
Corresponding Author : Choon-Keun Park, College of Animal Life Sciences, Kangwon National University, Chuncheon 24341, Korea. Tel.: +82-33-250-8627, E-mail: parkck@kangwon.ac.kr

© Copyright 2018 The Korean Society of Developmental Biology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Jun 06, 2018 ; Revised: Jun 20, 2018 ; Accepted: Jun 26, 2018

Published Online: Jun 30, 2018

ABSTRACT

This study aimed to investigate changes in the activity and mRNA expression of plasminogen activators (PAs) induced by 17β-estradiol (E2), human chorionic gonadotropin (hCG), and interleukin-1β (IL-1β) in porcine endometrial cells. Endometrial cells were isolated from the epithelium and cultured to 80% confluence. They were then treated for 24 h with E2 (0.2, 2, 20, and 200 ng/mL), IL-1β (0.1, 1, 10, and 100 ng/mL), and hCG (0.5, 1, 1.5 and 2 IU/mL). mRNA expressions of urokinase-type (uPA) and tissue-type (tPA) PAs were analyzed using reverse transcription PCR, and activities were measured using a PA activity assay. mRNA expressions of uPA and tPA increased with E2 treatment; however, this was not significant. Similarly, treatment with hCG did not influence the mRNA expressions of PAs. Interestingly, treatment with 0.1 ng/mL IL-1β significantly reduced the mRNA expression of uPA, but did not affect that of tPA. Treatment with 2, 20, and 200 ng/mL E2 increased PA activity compared with the control group; treatment with 0.1 and 1 ng/mL IL-1β significantly increased PA activity compared with the other IL-1β treatment groups, whereas treatment with 10 and 100 ng/mL IL-1β decreased. Treatment with 2 IU/mL hCG increased PA activity compared with the other treatment groups, although there were no significant differences between the hCG and control groups. In conclusion, the activity and mRNA expression of PAs were differently regulated by the hormone/cytokine and its concentration in porcine endometrial cells. Therefore, understanding PA regulatory mechanisms may help to improve the reproductive potential of domestic animals.

Keywords: 17β-estradiol; Human chorionic gonadotropin; Interleukin-1β; Plasminogen activators; Porcine endometrial cells

INTRODUCTION

The uterus secretes various growth factors, cytokines, and nutrients essential for embryo growth, implantation, and gestation. During the estrous cycle, it undergoes morphological and physiological changes such as increased thickness of the glandular epithelium and endometrium, angiogenesis, gene expression, and cytokine secretion (Stroband et al., 1986; Baker et al., 1998; Demir et al., 2010; Franczak et al., 2013). In particular, tissue remodeling of the mammalian uterus, which includes angiogenesis and increased number of secretory cells in the endometrium, provides a suitable environment for the survival and growth of the embryo and implantation of the conceptus. These changes within the uterine microenvironment are regulated by gonadotropins, hormones, and cytokines.

Estrogen is one of the main sex hormones of the female reproductive system and plays an important role in reproductive processes, such as uterine tissue remodeling and implantation recognition (Bazer & Johnson, 2014). This hormone is secreted from the ovaries and affects the endometrium blood vessels. In particular, the porcine conceptus produces 17β-estradiol (E2), a type of estrogen that prepares the endometrium for implantation during the pre-implantation period (Bazer & Johnson, 2014).

Human chorionic gonadotropin (hCG) has the same receptor and similar function as luteinizing hormone (LH) (Bolzan et al., 2013). Generally, it has been used for the induction of estrous and ovulation in pigs (Wongkaweewit et al., 2013) and cows (Giordano et al., 2012). In the mammalian endometrium, prostaglandin (PG) synthesis is regulated by LH via increased PG-endoperoxide synthase 2 in uterine cells, and the uterine environment is altered to begin the luteal phase (Sugino, 2014).

Interleukin-1β (IL-1β) from the conceptus is an important cytokine for implantation in pigs and plays a role in implantation and gestation as an autocrine and/or paracrine factor (Bazer & Johnson, 2014). As a paracrine factor, IL-1β acts on luminal epithelial cells through its receptors (interleukin-1 receptor, IL-1R) (Subramaniam et al., 2004). Thus, understanding the effects of hormones and cytokines on endometrial cells is highly important.

Plasminogen activators (PAs) are serine proteases that are present in two forms-urokinase-type (uPA) and tissue-type (tPA)-in most extracellular fluids, including seminal plasma (Kobayashi et al., 1992), uterine and oviductal fluid (Finlay et al., 1983; Kouba et al., 2000), and ovarian fluid (Beers, 1975). The plasmin converted from plasminogen by the PAs directly or indirectly degrades the extracellular matrix (ECM). Because of this feature, the PA system is associated with physiological processes including angiogenesis (Olofsson et al., 1998), activation of growth factors in the ECM (Menshikov et al., 2006), cell migration (Ploplis et al., 1998), and tissue remodeling (Martin and Arias, 1982). In addition, the PA system regulates the reproductive process. The two types of PAs are released from mammalian cumulus-oocyte complexes and are related to oocyte maturation and fertilization (Ebisch et al., 2008); moreover, plasma and acrosomal membranes of spermatozoa contain PAs to help penetrate the zona pellucida (Sa et al., 2010). In addition, epithelial cells in the oviducts and uterus express PAs and their inhibitors during the estrous cycle (Ahn et al., 2009; Hwangbo et al., 2013). Despite the PA system being closely associated with reproductive processes in the mammalian uterus, mechanisms underlying the regulation and activation of PAs in the uterus of domestic animals remain unclear. Therefore, the present study aimed to investigate changes in the activity and mRNA expression of PAs induced by E2, hCG, and IL-1β in porcine endometrial cells.

MATERIALS AND METHODS

1. Preparation of endometrial cells and treatment

A porcine uterus was collected from a local slaughterhouse and transported to the laboratory within 2 h on ice. The uterus was washed using Hank's Balanced Salt Solution (HBSS) and the ovaries and mesometrium were removed. The inside of the uterus was flushed using HBSS. The uterine horns were then cut along the vertical axis and epithelial cells were collected in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen, MA, USA) containing collagenase type I (66 unit/mL) by gently scraping the endometrial epithelium using a surgical blade. Epithelial cells were incubated in a shaking incubator (38℃, 120 rpm) to isolate them from the tissues. Isolated cells were filtered using a cell strainer (SPL Life Sciences, Korea) and centrifuged at 1,200 g for 5 min. Blood components were removed using Tris-NH4 and washed in HBSS. Collected cells were cultured in DMEM/F-12 containing 10% (v/v) FBS (Invitrogen), 0.2% (v/v) amphotericin B (Sigma-Aldrich, St. Louis, MO, USA), and 0.5% (v/v) antibiotic-antimycotic (ABAM, Invitrogen) at 38.5℃ in a 5% CO2 incubator, and the culture medium was changed every 48 h. When cells reached 80% confluence, different concentrations of E2 (0.2, 2, 20, and 200 ng/mL), IL-1β (0.1, 1, 10, and 100 ng/mL), or hCG (0.5, 1, 1.5 and 2 IU/mL) were added for 24 h.

2. Reverse transcription PCR

For mRNA extraction from cells, samples were treated with RNAiso Plus (Takara, Japan) and rotated for 10 min. Chloroform was then added to the RNAiso Plus followed by vortexing for 5 min. Extracted mRNA was separated by centrifugation (12,000 g, 4℃, 5 min) and washed with isopropyl alcohol followed by 75% ethanol. The dried mRNA pellet was mixed with DEPC-treated de-ionized water and mRNA concentrations were determined using the NanoDrop 2000 (Thermo Scientfic Nanodrop, Wilmington, DE, USA). cDNA was synthesized using Maxime RT PreMix (Intron Biotechnology, Korea) and PCR was conducted using primers (Table 1). The identities of PCR products were confirmed by 2% agarose gel electrophoresis containing ethidium bromide (EtBr, Bioneer, Korea). The relative mRNA expressions of uPA and tPA were normalized to GAPDH (glyceraldehyde 3-phosphate dehydrogenase), and ImageJ was used for image analysis.

Table 1. Primer sequences for reverse transcription PCR
Gene Primer sequence Product size (bp) Accession
uPA F:CCTACAAGTACTTCTC 460 NM_213945
R:GCAAACCAAGGCTGGTTTCTC
tPA F:AGGAGGCCTCTATGCTGACA 544 NM_214054
R:GGCACACAGCATATTGTTGG
GAPDH F:AAATGGGCACGTTGTGGGTG 200 AF017079
R:AGGCCAACCGGGAGAAGATG

uPA, urokinase-type plasminogen activator; tPA, tissue-type plasminogen activator; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Download Excel Table
3. PA activity assay

Samples of the collected culture medium (20 µL) were dispensed into a 96-well microplate and mixed with 30 µL of a plasminogen working solution (Sigma-Aldrich). The solution was incubated at 38℃ for 1 h. After incubation, substrate buffer [0.18 mM Z-L-Lys-SBzl hydrochloride, 0.22 mM 5,5′-dithiobis-(2-nitrobenzoic acid), and 0.01% Triton X-100] was added and was further incubated at 38℃ for 1 h. PA activity was determined by absorbance at the wavelength of 405 nm using a microplate reader.

4. Statistical analysis

All numerical data representing each parameter were analyzed using Statistical Analysis System software (SAS, version 9.4). Data are represented as the means±standard error of the mean (SEM) and were analyzed using Duncan's multiple range test. Comparisons among treatment groups were conducted using a generalized linear model in the SAS package. A value of p<0.05 was considered statistically significant.

RESULTS

1. Effects of E2, IL-1β, and hCG on mRNA expression of uPA and tPA in endometrial epithelial cells

Although the mRNA expression of uPA and tPA increased in E2-treated uterine cells, this was not significant (Fig. 1). Interestingly, treatment with 0.1 ng/mL IL-1β significantly reduced the mRNA expression of uPA (Fig. 2A, p<0.05), whereas that of tPA remained unchanged. Similar to the latter finding, the mRNA expression of neither PA was altered by hCG (Fig. 3).

dr-22-2-155-g1
Fig. 1. Effect of 17β-estradiol (E2; 0, 0.2, 2, 20, and 200 ng/mL) on the mRNA expression of two types of plasminogen activator (urokinase-type: uPA, A; tissue-type: tPA, B) in porcine endometrial cells. All data were presented as mean±SEM from 3 repeated experiments. PA, plasminogen activator; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Download Original Figure
dr-22-2-155-g2
Fig. 2. Effect of interleukin-1β (IL-1β; 0, 0.1, 1, 10, and 100 ng/mL) on the mRNA expression of two types of plasminogen activator (urokinase-type: uPA, A; tissue-type: tPA, B) in porcine endometrial cells.
Download Original Figure
dr-22-2-155-g3
Fig. 3. Effect of human chorionic gonadotropin (hCG; 0, 0.5, 1, 1.5, and 2 IU/mL) on the mRNA expression of two types of plasminogen activator (urokinase-type: uPA, A; tissue-type: tPA, B) in porcine endometrial cells.
Download Original Figure
2. Change in PA activity induced by E2, IL-1β, and hCG treatment in endometrial epithelial cells

PA activity significantly increased following treatment with 2, 20, and 200 ng/mL E2 compared with the control group (Fig. 4A, p<0.05), which was similar to the tendency in the mRNA expression of PAs to increase. Treatment with 0.1 and 1 ng/mL IL-1β significantly increased PA activity compared with the other groups, whereas 10 and 100 ng/mL IL-1β decreased PA activity (Fig. 4B, p<0.05). This pattern of PA activity was contrary to the mRNA expression of uPA seen following IL-1β treatment. Unlike mRNA expression, PA activity increased in 2 IU/mL hCG-treated cells compared with the other treatment groups; however, none of the hCG groups were significantly different from the control group (Fig. 4C).

dr-22-2-155-g4
Fig. 4. Changes in plasminogen activator activity induced by different concentrations of 17β-estradiol (E2; 0, 0.2, 2, 20, and 200 ng/mL; A), interleukin-1β (IL-1β; 0, 0.1, 1, 10, and 100 ng/mL; B), and human chorionic gonadotropin (hCG; 0, 0.5, 1, 1.5, and 2 IU/mL; C) in porcine endometrial cells. All data were presented as mean±SEM from 3 repeated experiments. a-c Different superscript indicates a significant difference (p<0.05). PA, plasminogen activator; hCG, human chorionic gonadotropin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Download Original Figure

DISCUSSION

This study was conducted to confirm the effects of E2, hCG, or IL-1β on the mRNA expression and activity of two types of PA in porcine endometrial epithelial cells. mRNA expression of uPA decreased only with 0.1 ng/mL IL-1β treatment, whereas that of tPA remained unchanged. Interestingly, altered PA activity resulting from treatment with different concentrations of E2 showed a similar pattern to mRNA expression of PA. Conversely, a pattern of PA activity that was different from that of the mRNA expression of uPA was seen after IL-1β treatment.

During the estrous cycle in mammals, morphological and physiological features of the uterus are altered by a number of hormones, cytokines, and chemokines, and these are important for the survival of the embryo, implantation, and successful pregnancy. Cheon (2007) reported that collagens in the early-pregnant mouse uterus are regulated for successful implantation and pregnancy. In addition, the expression of various genes and proteins that act as essential regulators of uterine function and its microenvironment is controlled through the actions of hormones and cytokines during the estrous cycle. As tissue remodeling factors, PAs are present in the uterine tissue and their levels are altered during the estrous cycle (Kim et al., 2011). They play a role in reproductive and physiological processes including angiogenesis, oocyte maturation, embryo development, ovulation, activation of matrix metalloproteinases (MMPs), and degradation of collagens and ECM proteins (Ebisch et al., 2008). In particular, sperm-zona pellucida binding is decreased by both PAs in the cytoplasm and zona pellucida of porcine oocytes during fertilization (Coy et al., 2012), and Krania et al. (2015) reported that addition of tPA during the in vitro fertilization of bovine oocytes decreased embryo development and increased the expression of apoptosis-related genes in embryos. Therefore, regulatory mechanisms underlying PA mRNA expression and activation in the female reproductive tract are important for animal reproduction.

Steroid hormones, including estrogen, progesterone, and androgens, play a pivotal role in uterine endometrial function in mammals (Cheon et al., 2009). During endometrial growth in the rat uterus, the thickness of the luminal epithelium increased with estrogen treatment (Lai et al., 2000). Estrogen and progesterone regulate reproduction via genomic and non-genomic actions (Stormshak & Bishop, 2008). In the present study, treatment with E2 enhanced PA activity, but did not influence the mRNA expression of PA. This suggests that estrogen may has influenced to translation or post-translation processes for the activation of PAs via non-genomic actions. Furthermore, we expect that an E2-induced increase in PA activity could be responsible for the tissue remodeling associated with angiogenesis, increased growth of the glandular epithelium, and enhanced thickness of the endometrium during the estrous cycle and implantation in pigs. However, effects of estrogen on the translational and post-translational processes of PAs in porcine endometrial cells require further research.

Generally, hCG has been used to induce ovulation in pigs (Brussow et al., 2009). As hCG has a similar structure to LH, it interacts with the LH receptor within the ovary. During the estrous cycle in pigs, a rapid increase in LH concentration known as the LH surge occurs before ovulation, inducing ovulation through rupture of the ovarian wall. At the same time, both uPA and tPA are produced in the granulosa and thecal cells of rat follicles by gonadotropins (Ny et al., 1985; Liu et al., 1987). Kim et al. (2011) reported that PA activity in porcine uterine tissue increased during the post-ovulatory period compared with the pre-ovulatory period. In this study, the activation of PAs in endometrial cells was stimulated by 2 IU/mL hCG treatment. In the uterus and oviducts, hCG influences PG synthase expression and PG synthesis (Shemesh et al., 2001; Malysz-Cymborska et al., 2013), and the actions of hCG in the female reproductive tract are important for gamete transport and survival. PA activity stimulated by hCG may play a role in uterine tissue remodeling and regulation of the intrauterine environment, thereby enabling embryo survival.

During the pre-implantation period, the conceptus trophectoderm of the pig secretes IL-1β, which is associated with elongation and pregnancy recognition (Ross et al., 2003). Interaction between the endometrium and conceptus via IL-1β is an important phenomenon for successful implantation in pigs. In addition, proliferation of uterine epithelial cells is stimulated by IL-1β via activation of the extracellular signal-regulated kinase (ERK) 1/2 mitogen-activated protein kinase (MAPK) signaling cascade (Jeong et al., 2016). In the present study, the mRNA expression of uPA was reduced by a low concentration of IL-1β, al-though tPA mRNA was not affected. PA activity increased in the low concentration groups (0.1 and 1 ng/mL), whereas it decreased by 10 and 100 ng/mL IL-1β. ERK/MAPK signaling regulates cellular processes including gene expression, protein synthesis, cell migration, and proliferation. The activation of IL-1β-induced ERK/MAPK signaling has been reported to be dose- and time-dependent (Jeong et al., 2016). Ny et al (1985) reported that the two types of PAs were differently regulated in granulosa cells by gonadotropins. Therefore, differential patterns of the mRNA expression of PA and PA activity may be regulated by the IL-1β-mediated ERK/MAPK signaling cascade.

In this work, we found that the mRNA expression of uPA and tPA is differently regulated by IL-1β in porcine endometrial cells, and treatment with E2, hCG, or IL-1β influenced the activation of PAs. During the estrous cycle and implantation period, the PA system plays an important role in tissue remodeling, including angiogenesis and effects on secretory glands and thickness of the endometrium. These results suggest that regulation of PA expression and activation by hormones and cytokines in the porcine uterus is critical for successful pregnancy. Understanding the PA regulatory mechanism may help improve the reproductive potential of domestic animals.

ACKNOWLEDGEMENT

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Education) (2016R1D1A1B03931746) and this study was supported by 2017 Research Grant from Kanwon national University (No. 520170230).

REFERENCES

1.

Ahn SH, Cheong HT, Yang BK, Kim DY, Park CK. 2009; Relationship between plasminogen activity and plasminogen inhibitor during the culture of porcine oviduct epithelial cell. Reprod Dev Biol. 33:203-209.

2.

Baker VL, Draper M, Paul S, Allerheiligen S, Glant M, Shifren J, Jaffe RB. 1998; Reproductive endocrine and endometrial effects of raloxifene hydrochloride a selective estrogen receptor modulator in women with regular menstrual cycles. J Clin Endocrinol Metab. 83:6-13.

3.

Bazer FW, Johnson GA. 2014; Pig blastocyst-uterine interaction. Differentiation. 87:52-65.

4.

Beers WH. 1975; Follicular plasminogen and plasminogen activator and the effect of plasmin on ovarian follicle wal. Cell. 6:379-386.

5.

Bolzan E, Andronowska A, Bodek G, Morawska-Pucinska E, Krawczynski K, Dabrowski A, Ziecik AJ. 2013; The novel effect of hCG administration on luteal function maintenance during the estrous cycle/pregnancy and early embryo development in the pi. Pol J Vet Sci. 16:323-332.

6.

Brussow KP, Schneider F, Kanitz W, Ratky J, Kauffold J, Wahner M. 2009; Studies on fixed-time ovulation induction in the pi. Soc Reprod Fertil Suppl. 66:187-195.

7.

Cheon YP. 2007; Altering of collagens in early pregnant mouse uteru. Dev Reprod. 11:1-11.

8.

Cheon YP, Lee DM, Chun TH, Lee KH, Choi IH. 2009; Androgen in the uterus: A compensator of estrogen and progesteron. Dev Reprod. 13:133-143.

9.

Coy P, Jimenez-Movilla M, Garcia-Vazquez FA, Mondejar I, Grullon L, Romar R. 2012; Oocytes use the plasminogen-plasmin system to remove supernumerary spermatozo. Hum Reprod. 27:1985-1993.

10.

Demir R, Yaba A, Huppertz B. 2010; Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantatio. Acta Histochem. 112:203-214.

11.

Ebisch IMW, Thomas CMG, Wetzels AMM, Willemsen WNP, Sweep FCGJ, Steegers-Theunissen RPM. 2008; Review of the role of the plasminogen activators system and vascular endothelial growth factor in subfertilit. Fertil Steril. 90:2340-2350.

12.

Finlay TH, Katz J, Kirsch L, Levitz M, Nathoo SA, Seiler S. 1983; Estrogen-stimulated uptake of plasminogen by the mouse uteru. Endocrinology. 112:856-861.

13.

Franczak A, Wojciechowicz B, Kotwica G. 2013; Transcriptomic analysis of the porcine endometrium during early pregnancy and the estrous cycl. Reprod Biol. 13:229-237.

14.

Giordano JO, Wiltbank MC, Guenther JN, Ares MS, Lopes G, Herlihy MM, Fricke PM. 2012; Effect of presynchronization with human chorionic gonadotropin or gonadotropin-releasing hormone 7 days before resynchronization of ovulation on fertility in lactating dairy cow. J Dairy Sci. 95:5612-5625.

15.

Hwangbo Y, Lee SH, Cha HJ, Song EJ, Lee ST, Lee ES, Cheong HT, Yang BK, Park CK. 2013; Expression of plasminogen activators in uterine epithelial cells of pre-ovulatory phase in pig. J Emb Trans. 28:257-263.

16.

Jeong W, Kim J, Bazer FW, Song G, Kim J. 2016; Stimulatory effects of interleukin-1 beta on development of porcine uterine epithelial cell are mediated by activation of the ERK1/2 MAPK cell signaling cascad. Mol Cell Endocrinol. 419:225-234.

17.

Kim KH, Lee YS, Gu HN, Yang BK, Cheong HT, Park CK. 2011; Changes in plasminogen activity in uterus tissue during the estrous cycle in the pig. Reprod Dev Biol. 35:463-468.

18.

Kobayashi T, Matsuda Y, Park JY, Hara I, Kaneko S, Fujimoto Y, Nozawa S, Akihama S. 1992; Trypsin-like arginine amidases including plasminogen and plasmin in human seminal plasma by affinity adsorption and elutio. Arch Androl. 28:165-170.

19.

Kouba AJ, Burkhardt BR, Alvarez IM, Goodenow MM, Buhi WC. 2000; Oviductal plasminogen activator inhibitor (PAI-1): mRNA protein and hormonal regulation during the estrous cycle and early pregnancy in the pi. Mol Reprod Dev. 56:378-386.

20.

Krania F, Dovolou E, Rekkas CA, Theodosiadou EK, Pappas I, Amiridis GS. 2015; Effects of addition of tissue-type plasminogen activator in in vitro fertilization medium on bovine embryo development and qualit. Reprod Domest Anim. 50:112-120.

21.

Lai MD, Lee LR, Cheng KS, Wing LY. 2000; Expression of proliferating cell nuclear antigen in luminal epithelium during the growth and regression of rat uteru. J Endocrinol. 166:87-93.

22.

Liu YX, Cajander SB, Ny T, Kristensen P, Hsueh AJW. 1987; Gonadotropin regulation of tissue-type and urokinase-type plasminogen activators in rat granulosa and theca-interstitial cells during the periovulatory perio. Mol Cell Endocrinol. 54:221-229.

23.

Malysz-Cymborska I, Ziecik AJ, Waclawik A, Andronowska A. 2013; Effect of hCG and eCG treatments on prostaglandins synthesis in the porcine oviduc. Reprod Domest Anim. 48:1034-1042.

24.

Martin O, Arias F. 1982; Plasminogen activator production by trophoblast cells in vitro: Effect of steroid hormones and protein synthesis inhibitor. Am J Obstet Gynecol. 142:402-409.

25.

Menshikov M, Plekhanova O, Cai H, Chalupsky K, Parfyonova Y, Bashtrikov P, Tkachuk V, Berk BC. 2006; Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathway. Arterioscler Thromb Vasc Biol. 26:801-807.

26.

Ny T, Bjersing L, Hsueh AJW, Loskutoff DJ. 1985; Cultured granulosa cells produce two plasminogen activators and an ant iactivator each regulated differently by gonadotropin. Endocrinology. 166:1666-1668.

27.

Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U. 1998; Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cell. Proc Natl Acad Sci USA. 95:11709-11714.

28.

Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. 1998; Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mic. Blood. 91:2005-2009.

29.

Ross JW, Ashworth MD, Hurst AG, Malayer JR, Geisert RD. 2003; Analysis and characterization of differential gene expression during rapid trophoblastic elongation in the pig using suppression subtractive hybridizatio. Reprod Biol Endocrinol. 1:23.

30.

Sa SJ, Park CK, Kim IC, Lee SH, Kwon OS, Kim MJ, Cho KH, Kim DW, So KM, Cheong HT. 2010; Effects of reactive oxygen species (ROS) on sperm function and plasminogen activator activity in porcine spermatozo. Reprod Dev Biol. 34:185-191.

31.

Shemesh M, Mizrachi D, Gurevich M, Shore LS, Reed J, Chang SM, Thatcher WW, Fields MJ. 2001; Expression of functional luteinizing hormone (LH) receptor and its messenger ribonucleic acid in bovine endometrium: LH augmentation of cAMP and inositol phosphate in vitro and human chorionic gonadotropin (hCG) augmentation of peripheral prostaglandin in viv. Reprod Biol. 1:13-32.

32.

Stormshak F, Bishop CV. 2008; Board-invited review: Estrogen and progesterone signaling: Genomic and nongenomic actions in domestic ruminant. J Anim Sci. 86:299-315.

33.

Stroband HWJ, Taverne N, Langenfeld K, Barends PMG. 1986; The ultrastructure of the uterine epithelium of the pig during the estrous cycle and early pregnanc. Cell Tissue Res. 246:81-89.

34.

Subramaniam S, Stansberg C, Cunningham C. 2004; The interleukin 1 receptor famil. Dev Comp Immunol. 28:415-428.

35.

Sugino N. 2014; Molecular mechanisms of luteinizatio. Obstet Gynecol Sci. 57:93-101.

36.

Wongkaweewit K, Prommachart P, Raksasub R, Buranaamnuay K, Techakumphu M, De Rensis F, Tummaruk P. 2012; Effect of the administration of GnRH or hCG on time of ovulation and the onset of estrus-to-ovulation interval in sows in Thailan. Trop Anim Health Pro. 44:467-470.